Skip to main content

Selection of Abilify Gambling Cases for 2nd Bellwether Trial

Selection of Abilify Gambling Cases for 2nd Bellwether Trial

Selection of Abilify Gambling Cases for 2nd Bellwether Trial

Introduction

U.S. District Judge M. Casey Rodgers ordered parties involved in the Abilify gambling litigation to reach on a common agreement regarding the selection of trial cases by the end of this year, for proceeding with the second bellwether trial.

In an order issued on Friday, Judge Rodgers indicated that a group of 100 cases must be picked randomly by July 6 for the second trial pool. The court will choose 40 cases from that pool which the plaintiffs have to agree to be tried in the multidistrict litigation (MDL). By December 21, 2018, the parties can strike off additional 10 cases each, thus reducing the pool count to 20. These cases will undergo fact-discovery and depositions before the parties finalize 10 crucial cases for bellwether trial. Jude Rodgers further stated that “The parties will meet and confer on the timing and scope of expert discovery for those 10 cases.”

If any cases need to be removed from the final trial pool, the Court will randomly replace it with the discarded cases from the second discovery pool. By September 28, 2018, the plaintiffs are required to submit a detailed Plaintiff Fact Sheet (PFS) along with authorizations for the release of medical, financial and gambling records. The outcome of these bellwethers trials will help gauge how the jury may respond to other lawsuits in the litigation.

Bristol-Myers Squibb and Otsuka Pharmaceuticals have more than 1,100 lawsuits in the federal court over failure to warn about Abilify gambling risk. Abilify lawsuits were centralized in October 2016, as a part of MDL No. 2734 (In Re: Abilify Compulsive Behavior Products Liability Litigation) before Judge M. Casey Rodgers in the U.S. District Court for the Northern District of Florida.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!